KIT and mastocytosis: This was firstly recognized in 1995, when Nagata et al. [86] identified a point mutation in exon 17, resulting in a substitution of valine for aspartic acid in the catalytic domain of the KIT gene (D816V) in the peripheral blood of four patients with mastocytosis.